{"transactions":[{"id":1745808,"issuer":{"id":108311,"kind":"organization","name":"EQRx, Inc.","symbol":"EQRX"},"owners":[{"id":108431,"kind":"person","name":"Abernethy Amy","position":1,"cik":"0001590728","reported_name":"Abernethy Amy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-11-09T16:06:29.000Z","date":"2023-11-09","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":389223,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger dated July 31, 2023 (the \"Merger Agreement\"), by and among the Issuer, Revolution Medicines, Inc. (\"Revolution Medicines\"), Equinox Merger Sub, Inc., a direct, wholly owned subsidiary of Revolution Medicines (\"Merger Sub I\"), and Equinox Merger Sub II LLC, a direct, wholly owned subsidiary of Revolution Medicines (\"Merger Sub II\"), pursuant to which Merger Sub I merged with and into the Issuer effective as of November 9, 2023 (the \"Effective Time\"), with the Issuer surviving such merger as a direct, wholly owned subsidiary of Revolution Medicines (the \"First Merger\"), and promptly after the First Merger, the Issuer merged with and into Merger Sub II, with Merger Sub II surviving such merger as a direct, wholly owned subsidiary of Revolution Medicines."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, each Issuer stock option that was outstanding and unexercised became fully vested and exercisable as of immediately prior to the Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"At the Effective Time, each Issuer stock option that was outstanding immediately prior to the Effective Time and had an exercise price per share less than $2.16 (an \"In-the-Money Option\") was cancelled and converted automatically into the right to receive a number of shares of Revolution Medicines common stock equal to the quotient of (i) the product of (a) the number of shares of Issuer common stock subject to the In-the-Money Option immediately prior to the Effective Time, multiplied by (b) the excess of $2.16 over the exercise price of such In-the-Money Option, divided by (ii) $19.4690, less the number of shares of Revolution Medicines common stock having a fair market value as of the Effective Time equal to the amount necessary to satisfy the award holder's tax withholding obligations. (All Issuer stock options that did not constitute In-the-Money Options were terminated at the Effective Time for no consideration)."}],"balance_after":0,"derivative":{"exercise_price":3.03,"expiration_date":"2032-02-25","underlying":"Common Stock","underlying_shares":389223},"source":{"system":"sec-edgar","filing":"0000899243-23-020292","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1843762/000089924323020292/doc4.xml","form_type":"4"}},{"id":1745807,"issuer":{"id":108311,"kind":"organization","name":"EQRx, Inc.","symbol":"EQRX"},"owners":[{"id":108431,"kind":"person","name":"Abernethy Amy","position":1,"cik":"0001590728","reported_name":"Abernethy Amy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-11-09T16:06:29.000Z","date":"2023-11-09","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":200000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger dated July 31, 2023 (the \"Merger Agreement\"), by and among the Issuer, Revolution Medicines, Inc. (\"Revolution Medicines\"), Equinox Merger Sub, Inc., a direct, wholly owned subsidiary of Revolution Medicines (\"Merger Sub I\"), and Equinox Merger Sub II LLC, a direct, wholly owned subsidiary of Revolution Medicines (\"Merger Sub II\"), pursuant to which Merger Sub I merged with and into the Issuer effective as of November 9, 2023 (the \"Effective Time\"), with the Issuer surviving such merger as a direct, wholly owned subsidiary of Revolution Medicines (the \"First Merger\"), and promptly after the First Merger, the Issuer merged with and into Merger Sub II, with Merger Sub II surviving such merger as a direct, wholly owned subsidiary of Revolution Medicines."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"At the Effective Time, each share of Issuer common stock that was issued and outstanding immediately prior to the Effective Time was converted into the right to receive a number of validly issued, fully paid and non-assessable shares of Revolution Medicines common stock equal to 0.1112 (the \"Exchange Ratio\") and cash in lieu of any fractional shares of Revolution Medicines common stock any former holder of Issuer common stock would otherwise be entitled to receive, without interest and subject to any required tax withholding, upon the terms and subject to the conditions of the Merger Agreement."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-23-020292","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1843762/000089924323020292/doc4.xml","form_type":"4"}},{"id":2000146,"issuer":{"id":108311,"kind":"organization","name":"EQRx, Inc.","symbol":"EQRX"},"owners":[{"id":108431,"kind":"person","name":"Abernethy Amy","position":1,"cik":"0001590728","reported_name":"Abernethy Amy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-22T16:07:58.000Z","date":"2022-09-30","kind":"grant","acquired":true,"shares":0,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"This Form 4/A amends and restates the original Form 4 filed on October 4, 2022 (the \"Original Form 4\"). The stock option reported on the Original Form 4 was reported in error and was never granted to the Reporting Person."},{"field":"shares","element":"transactionShares","label":"F1","text":"This Form 4/A amends and restates the original Form 4 filed on October 4, 2022 (the \"Original Form 4\"). The stock option reported on the Original Form 4 was reported in error and was never granted to the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This Form 4/A amends and restates the original Form 4 filed on October 4, 2022 (the \"Original Form 4\"). The stock option reported on the Original Form 4 was reported in error and was never granted to the Reporting Person."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"This Form 4/A amends and restates the original Form 4 filed on October 4, 2022 (the \"Original Form 4\"). The stock option reported on the Original Form 4 was reported in error and was never granted to the Reporting Person."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":0},"source":{"system":"sec-edgar","filing":"0001104659-23-024299","document":"tm237528-2_4aseq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1843762/000110465923024299/tm237528-2_4aseq1.xml","form_type":"4/A","original_submission_date":"2022-10-04"}},{"id":2000150,"issuer":{"id":108311,"kind":"organization","name":"EQRx, Inc.","symbol":"EQRX"},"owners":[{"id":108431,"kind":"person","name":"Abernethy Amy","position":1,"cik":"0001590728","reported_name":"Abernethy Amy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-22T16:05:42.000Z","date":"2022-02-25","kind":"grant","acquired":true,"shares":389223,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This Form 4/A amends and restates the original Form 4 filed on March 1, 2022 (the \"Original Form 4\"). The number of shares of Common Stock subject to the stock option granted to the Reporting Person on February 25, 2022 was erroneously reported as 449,644 in the Original Form 4."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-third of the shares underlying this option shall vest and become exercisable on December 17, 2022, with the remainder vesting in eight substantially equal quarterly installments thereafter, subject to the Reporting Person's continuous service as of each vesting date."}],"balance_after":389223,"derivative":{"exercise_price":3.03,"expiration_date":"2032-02-25","underlying":"Common Stock","underlying_shares":389223},"source":{"system":"sec-edgar","filing":"0001104659-23-024293","document":"tm237528-1_4aseq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1843762/000110465923024293/tm237528-1_4aseq1.xml","form_type":"4/A","original_submission_date":"2022-03-01"}},{"id":2144964,"issuer":{"id":108311,"kind":"organization","name":"EQRx, Inc.","symbol":"EQRX"},"owners":[{"id":108431,"kind":"person","name":"Abernethy Amy","position":1,"cik":"0001590728","reported_name":"Abernethy Amy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-10-04T20:07:54.000Z","date":"2022-09-30","kind":"grant","acquired":true,"shares":101010,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option shall vest and become exercisable in full September 30, 2023, the one-year anniversary of the grant date, subject to the Reporting Person's continuous service on such vesting date, and subject to full acceleration upon the consummation of a Sale Event (as defined in the Issuer's 2021 Stock Option and Incentive Plan)."}],"balance_after":101010,"derivative":{"exercise_price":4.95,"expiration_date":"2032-09-30","underlying":"Common Stock","underlying_shares":101010},"source":{"system":"sec-edgar","filing":"0001104659-22-106025","document":"tm2227449-8_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1843762/000110465922106025/tm2227449-8_4seq1.xml","form_type":"4"}},{"id":2365775,"issuer":{"id":108311,"kind":"organization","name":"EQRx, Inc.","symbol":"EQRX"},"owners":[{"id":108431,"kind":"person","name":"Abernethy Amy","position":1,"cik":"0001590728","reported_name":"Abernethy Amy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-01T17:27:36.000Z","date":"2022-02-25","kind":"grant","acquired":true,"shares":449644,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the shares underlying this option shall vest and become exercisable on December 17, 2022, with the remainder vesting in eight substantially equal quarterly installments thereafter, subject to the Reporting Person's continuous service as of each vesting date."}],"balance_after":449644,"derivative":{"exercise_price":3.03,"expiration_date":"2032-02-25","underlying":"Common Stock","underlying_shares":449644},"source":{"system":"sec-edgar","filing":"0001213900-22-010122","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1843762/000121390022010122/ownership.xml","form_type":"4"}},{"id":2462634,"issuer":{"id":108311,"kind":"organization","name":"EQRx, Inc.","symbol":"EQRX"},"owners":[{"id":108431,"kind":"person","name":"Abernethy Amy","position":1,"cik":"0001590728","reported_name":"Abernethy Amy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class B Common Stock","published_at":"2021-12-21T06:30:23.000Z","date":"2021-12-17","kind":"exercise","acquired":false,"shares":200000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Immediately prior to the consummation of the transactions (the \"Closing\" of the \"Business Combination\") contemplated by the Agreement and Plan of Merger dated August 5, 2021 (the \"Merger Agreement\") by and among the Issuer (f/k/a CM Life Sciences III Inc.), Clover III Merger Sub Inc. and EQRx International, Inc. (f/k/a EQRx, Inc., \"Legacy EQRx\"), each share of the Issuer's Class B Common Stock automatically converted into shares of Class A Common Stock on a one-for-one basis (the \"Conversion\")."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Immediately prior to the consummation of the transactions (the \"Closing\" of the \"Business Combination\") contemplated by the Agreement and Plan of Merger dated August 5, 2021 (the \"Merger Agreement\") by and among the Issuer (f/k/a CM Life Sciences III Inc.), Clover III Merger Sub Inc. and EQRx International, Inc. (f/k/a EQRx, Inc., \"Legacy EQRx\"), each share of the Issuer's Class B Common Stock automatically converted into shares of Class A Common Stock on a one-for-one basis (the \"Conversion\")."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Immediately prior to the consummation of the transactions (the \"Closing\" of the \"Business Combination\") contemplated by the Agreement and Plan of Merger dated August 5, 2021 (the \"Merger Agreement\") by and among the Issuer (f/k/a CM Life Sciences III Inc.), Clover III Merger Sub Inc. and EQRx International, Inc. (f/k/a EQRx, Inc., \"Legacy EQRx\"), each share of the Issuer's Class B Common Stock automatically converted into shares of Class A Common Stock on a one-for-one basis (the \"Conversion\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Immediately prior to the consummation of the transactions (the \"Closing\" of the \"Business Combination\") contemplated by the Agreement and Plan of Merger dated August 5, 2021 (the \"Merger Agreement\") by and among the Issuer (f/k/a CM Life Sciences III Inc.), Clover III Merger Sub Inc. and EQRx International, Inc. (f/k/a EQRx, Inc., \"Legacy EQRx\"), each share of the Issuer's Class B Common Stock automatically converted into shares of Class A Common Stock on a one-for-one basis (the \"Conversion\")."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Immediately prior to the consummation of the transactions (the \"Closing\" of the \"Business Combination\") contemplated by the Agreement and Plan of Merger dated August 5, 2021 (the \"Merger Agreement\") by and among the Issuer (f/k/a CM Life Sciences III Inc.), Clover III Merger Sub Inc. and EQRx International, Inc. (f/k/a EQRx, Inc., \"Legacy EQRx\"), each share of the Issuer's Class B Common Stock automatically converted into shares of Class A Common Stock on a one-for-one basis (the \"Conversion\")."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0000899243-21-049125","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1843762/000089924321049125/doc4.xml","form_type":"4"}},{"id":2462633,"issuer":{"id":108311,"kind":"organization","name":"EQRx, Inc.","symbol":"EQRX"},"owners":[{"id":108431,"kind":"person","name":"Abernethy Amy","position":1,"cik":"0001590728","reported_name":"Abernethy Amy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-21T06:30:23.000Z","date":"2021-12-17","kind":"other","acquired":true,"shares":200000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Immediately following the Conversion but prior to Closing, the Class A Common Stock was reclassified as Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Immediately following the Conversion but prior to Closing, the Class A Common Stock was reclassified as Common Stock."}],"balance_after":200000,"source":{"system":"sec-edgar","filing":"0000899243-21-049125","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1843762/000089924321049125/doc4.xml","form_type":"4"}},{"id":2462632,"issuer":{"id":108311,"kind":"organization","name":"EQRx, Inc.","symbol":"EQRX"},"owners":[{"id":108431,"kind":"person","name":"Abernethy Amy","position":1,"cik":"0001590728","reported_name":"Abernethy Amy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-12-21T06:30:23.000Z","date":"2021-12-17","kind":"other","acquired":false,"shares":200000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Immediately following the Conversion but prior to Closing, the Class A Common Stock was reclassified as Common Stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Immediately following the Conversion but prior to Closing, the Class A Common Stock was reclassified as Common Stock."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-21-049125","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1843762/000089924321049125/doc4.xml","form_type":"4"}},{"id":2462631,"issuer":{"id":108311,"kind":"organization","name":"EQRx, Inc.","symbol":"EQRX"},"owners":[{"id":108431,"kind":"person","name":"Abernethy Amy","position":1,"cik":"0001590728","reported_name":"Abernethy Amy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2021-12-21T06:30:23.000Z","date":"2021-12-17","kind":"exercise","acquired":true,"shares":200000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Immediately prior to the consummation of the transactions (the \"Closing\" of the \"Business Combination\") contemplated by the Agreement and Plan of Merger dated August 5, 2021 (the \"Merger Agreement\") by and among the Issuer (f/k/a CM Life Sciences III Inc.), Clover III Merger Sub Inc. and EQRx International, Inc. (f/k/a EQRx, Inc., \"Legacy EQRx\"), each share of the Issuer's Class B Common Stock automatically converted into shares of Class A Common Stock on a one-for-one basis (the \"Conversion\")."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Immediately prior to the consummation of the transactions (the \"Closing\" of the \"Business Combination\") contemplated by the Agreement and Plan of Merger dated August 5, 2021 (the \"Merger Agreement\") by and among the Issuer (f/k/a CM Life Sciences III Inc.), Clover III Merger Sub Inc. and EQRx International, Inc. (f/k/a EQRx, Inc., \"Legacy EQRx\"), each share of the Issuer's Class B Common Stock automatically converted into shares of Class A Common Stock on a one-for-one basis (the \"Conversion\")."}],"balance_after":200000,"source":{"system":"sec-edgar","filing":"0000899243-21-049125","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1843762/000089924321049125/doc4.xml","form_type":"4"}},{"id":3689184,"issuer":{"id":4344,"kind":"organization","name":"CareDx, Inc.","symbol":"CDNA"},"owners":[{"id":108431,"kind":"person","name":"Abernethy Amy","position":1,"cik":"0001590728","reported_name":"Abernethy Amy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-01-24T02:44:20.000Z","date":"2019-01-22","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/36th of the shares subject to the option vested on August 2, 2018 and 1/36th of the shares subject to the option vested or vest monthly thereafter."}],"balance_after":25000,"derivative":{"exercise_price":12.88,"expiration_date":"2028-07-01","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0000899243-19-001830","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1217234/000089924319001830/doc4.xml","form_type":"4"}},{"id":3689183,"issuer":{"id":4344,"kind":"organization","name":"CareDx, Inc.","symbol":"CDNA"},"owners":[{"id":108431,"kind":"person","name":"Abernethy Amy","position":1,"cik":"0001590728","reported_name":"Abernethy Amy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-01-24T02:44:20.000Z","date":"2019-01-22","kind":"exercise","acquired":true,"shares":5000,"price":12.88,"value":64400.0,"ownership":{"direct":true},"balance_after":15837,"source":{"system":"sec-edgar","filing":"0000899243-19-001830","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1217234/000089924319001830/doc4.xml","form_type":"4"}},{"id":3708024,"issuer":{"id":4344,"kind":"organization","name":"CareDx, Inc.","symbol":"CDNA"},"owners":[{"id":108431,"kind":"person","name":"Abernethy Amy","position":1,"cik":"0001590728","reported_name":"Abernethy Amy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-01-04T02:12:37.000Z","date":"2019-01-02","kind":"grant","acquired":true,"shares":437,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an automatic quarterly grant of common stock to the reporting person in lieu of cash for non-employee director compensation pursuant to the issuer's Outside Director Compensation Policy."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,500 restricted stock units granted on July 1, 2018, the vesting of which was accelerated in full by the Issuer on December 17, 2018."}],"balance_after":10837,"source":{"system":"sec-edgar","filing":"0000899243-19-000353","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1217234/000089924319000353/doc4.xml","form_type":"4"}},{"id":3800840,"issuer":{"id":4344,"kind":"organization","name":"CareDx, Inc.","symbol":"CDNA"},"owners":[{"id":108431,"kind":"person","name":"Abernethy Amy","position":1,"cik":"0001590728","reported_name":"Abernethy Amy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-10-03T01:14:29.000Z","date":"2018-10-01","kind":"grant","acquired":true,"shares":400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an automatic quarterly grant of common stock to the reporting person in lieu of cash for non-employee director compensation pursuant to the issuer's Outside Director Compensation Policy."}],"balance_after":10400,"source":{"system":"sec-edgar","filing":"0000899243-18-025911","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1217234/000089924318025911/doc4.xml","form_type":"4"}},{"id":3874384,"issuer":{"id":4344,"kind":"organization","name":"CareDx, Inc.","symbol":"CDNA"},"owners":[{"id":108431,"kind":"person","name":"Abernethy Amy","position":1,"cik":"0001590728","reported_name":"Abernethy Amy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-07-03T21:35:10.000Z","date":"2018-07-01","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/36th of the shares subject to the option shall vest on August 2, 2018 and 1/36th of the shares subject to the option shall vest monthly thereafter."}],"balance_after":30000,"derivative":{"exercise_price":12.88,"expiration_date":"2028-07-01","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000899243-18-019278","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1217234/000089924318019278/doc4.xml","form_type":"4"}},{"id":3874383,"issuer":{"id":4344,"kind":"organization","name":"CareDx, Inc.","symbol":"CDNA"},"owners":[{"id":108431,"kind":"person","name":"Abernethy Amy","position":1,"cik":"0001590728","reported_name":"Abernethy Amy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-03T21:35:10.000Z","date":"2018-07-01","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities are represented by restricted stock units 1/3rd of which shall vest on July 1, 2019 and 1/3rd of which shall vest on each anniversary thereafter."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0000899243-18-019278","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1217234/000089924318019278/doc4.xml","form_type":"4"}},{"id":3900260,"issuer":{"id":160326,"kind":"organization","name":"ATHENAHEALTH INC","symbol":"ATHN"},"owners":[{"id":108431,"kind":"person","name":"Abernethy Amy","position":1,"cik":"0001590728","reported_name":"Abernethy Amy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-08T18:18:15.000Z","date":"2018-06-06","kind":"grant","acquired":true,"shares":1931,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of restricted stock units (\"RSUs\") under the Issuer's 2007 Stock Option and Incentive Plan, as amended and restated (the \"2007 Plan\"), granted pursuant to the Issuer's 2018 Director Compensation Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs fully vest on June 6, 2019."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,931 units of common stock that were granted pursuant to RSU awards under the 2007 Plan. The RSUs are subject to time-based vesting and will be settled only in stock."}],"balance_after":5976,"source":{"system":"sec-edgar","filing":"0001131096-18-000143","document":"wf-form4_152849627907207.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1131096/000113109618000143/wf-form4_152849627907207.xml","form_type":"4"}},{"id":4120295,"issuer":{"id":160326,"kind":"organization","name":"ATHENAHEALTH INC","symbol":"ATHN"},"owners":[{"id":108431,"kind":"person","name":"Abernethy Amy","position":1,"cik":"0001590728","reported_name":"Abernethy Amy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-12-28T21:38:01.000Z","date":"2017-12-26","kind":"sale","acquired":false,"shares":500,"price":134.18,"value":67090.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on October 25, 2017, in accordance with Rule 10b5-1."}],"balance_after":4045,"source":{"system":"sec-edgar","filing":"0001131096-17-000191","document":"wf-form4_151451506433306.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1131096/000113109617000191/wf-form4_151451506433306.xml","form_type":"4"}},{"id":4404979,"issuer":{"id":160326,"kind":"organization","name":"ATHENAHEALTH INC","symbol":"ATHN"},"owners":[{"id":108431,"kind":"person","name":"Abernethy Amy","position":1,"cik":"0001590728","reported_name":"Abernethy Amy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-03-03T16:49:45.000Z","date":"2017-03-01","kind":"grant","acquired":true,"shares":1896,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of restricted stock units (\"RSUs\") under the Issuer's 2007 Stock Option and Incentive Plan, as amended and restated, granted pursuant to the Issuer's 2017 Director Compensation Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs fully vest on March 1, 2018."}],"balance_after":4545,"source":{"system":"sec-edgar","filing":"0001131096-17-000034","document":"wf-form4_148857777082127.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1131096/000113109617000034/wf-form4_148857777082127.xml","form_type":"4"}},{"id":4517230,"issuer":{"id":160326,"kind":"organization","name":"ATHENAHEALTH INC","symbol":"ATHN"},"owners":[{"id":108431,"kind":"person","name":"Abernethy Amy","position":1,"cik":"0001590728","reported_name":"Abernethy Amy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-12-19T16:18:04.000Z","date":"2016-12-15","kind":"sale","acquired":false,"shares":1000,"price":117.15,"value":117150.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on September 9, 2016, in accordance with Rule 10b5-1."}],"balance_after":2649,"source":{"system":"sec-edgar","filing":"0001131096-16-000419","document":"wf-form4_148218227105716.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1131096/000113109616000419/wf-form4_148218227105716.xml","form_type":"4"}},{"id":4611381,"issuer":{"id":160326,"kind":"organization","name":"ATHENAHEALTH INC","symbol":"ATHN"},"owners":[{"id":108431,"kind":"person","name":"Abernethy Amy","position":1,"cik":"0001590728","reported_name":"Abernethy Amy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-09-06T16:53:50.000Z","date":"2016-09-01","kind":"sale","acquired":false,"shares":1000,"price":122.29,"value":122290.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on September 1, 2015, in accordance with Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.83 to $122.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Footnote (2)."}],"balance_after":3649,"source":{"system":"sec-edgar","filing":"0001131096-16-000378","document":"wf-form4_147319521795962.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1131096/000113109616000378/wf-form4_147319521795962.xml","form_type":"4"}}]}